Global Codeine Drug Market
Global Codeine Drug Market

Codeine Drug Comprehensive Study by Type (Tablets, Syrup), Sales Channels (Direct Sales, In-Direct Sales), End Users (Hospitals, Clinics), Treatment (Pain, Cough, Diarrhea, Others), Form (Tablets, Syrup) Players and Region - Global Market Outlook to 2026

Codeine Drug Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

Sep 2021 Edition 206 Pages 218 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
Industry Background:
The painkiller Codeine is an antibiotic of morphine that is used to reduce pain, coughing, and diarrhea. The sap of the opium poppy, Papaver somniferum, contains it naturally. It is most commonly used to relieve mild to moderate pain. When coupled with paracetamol (acetaminophen) or a nonsteroidal anti-inflammatory medicine (NSAID) like aspirin or ibuprofen, a greater benefit may be obtained. Its use for acute cough suppression in children or adults is not supported by evidence. It's usually consumed by mouth. It usually begins to operate after half an hour and reaches its peak effect after two hours.This growth is primarily driven by Rise in Number of Cough and Body Pain Cases in Current Pandemic.

Globally, a noticeable market trend is evident Leading Pharma Companies are Increasing Awareness Regarding Palliative Care Services. Major Players, such as Pfizer (United States), Abbott (United States), Merck (United States), Sanofi (France), Johnson and Johnson (United States), Janssen Pharmaceuticals (Belgium), Mallinckrodt Pharmaceuticals (United Kingdom), Endo Pharmaceuticals (Ireland), Assertio Therapeutics (United States) and Sun Pharma (India) etc have either set up their manufacturing facilities or are planning to start new provision in the dominated region in the upcoming years.

Key Developments in the Market:
In March 2020 Assertio Therapeutics released a Statement Stating Merger with Zyla Life Sciences. The merger will result in a top commercial pharmaceutical business with drugs in the areas of neurology, inflammation, and pain. Neurologists, orthopedic surgeons, internists, women's health professionals, podiatrists, and pain management specialists will benefit from the combined company's leading portfolio of branded non-steroidal anti-inflammatory medications (NSAIDs).

Market Drivers
  • Rise in Number of Cough and Body Pain Cases in Current Pandemic

Market Trend
  • Leading Pharma Companies are Increasing Awareness Regarding Palliative Care Services

Restraints
  • Long-Term Codeine Drug use Can Result in Alcoholism and Addiction
  • Many People Prefer Home-Made Medicines rather than Purchasing Prescription Drugs

Opportunities
More Improved Product Offers in Terms of Health Benefits and Convenience, as Well as Legal Compliance
Challenges
Side-Effects of Codeine Drugs

AMA Research follow a focused and realistic research framework that provides the ability to study the crucial market dynamics in several regions across the world. Moreover, an in-depth assessment is mostly conducted by our analysts on geographical regions to provide clients and businesses the opportunity to dominate in niche markets and expand in emerging markets across the globe. This market research study also showcase the spontaneously changing Players landscape impacting the growth of the market. Furthermore, our market researchers extensively analyse the products and services offered by multiple players competing to increase their market share and presence.

Customization in the Report
AMA Research features not only specific market forecasts, but also include significant value-added commentary on:
- Market Trends
- Technological Trends and Innovations
- Market Maturity Indicators
- Growth Drivers and Constraints
- New Entrants into the Market & Entry/Exit Barriers
- To Seize Powerful Market Opportunities
- Identify Key Business Segments, Market Proposition & Gap Analysis

Against this Challenging Backdrop, Codeine Drug Study Sheds Light on
— The Codeine Drug Market status quo and key characteristics. To end this, Analyst at AMA organize and took survey of the Codeine Drug industry Players. The resultant snapshot serves as a basis for understanding why and how the industry can be expected to change.
— Where Codeine Drug industry is heading and what are the top priorities. Insights are drawn from financial analysis, the survey and interviews with key executives and industry experts.
— How every company in this diverse set of Players can best navigate the emerging competition landscape and follow a strategy that helps them position to hold value they currently claim, or capture the new addressable opportunity.

Frequently Asked Questions (FAQ):

1. What are the years considered in the Codeine Drug Market?
Historical year: 2016-2020; Base year: 2020; Forecast period: 2021 to 2026

2. Who are the key players profiled in the Codeine Drug Market?
Companies that are profiled in Global Codeine Drug Market are Pfizer (United States), Abbott (United States), Merck (United States), Sanofi (France), Johnson and Johnson (United States), Janssen Pharmaceuticals (Belgium), Mallinckrodt Pharmaceuticals (United Kingdom), Endo Pharmaceuticals (Ireland), Assertio Therapeutics (United States) and Sun Pharma (India) etc.

3. What is Codeine Drug Market?
The painkiller Codeine is an antibiotic of morphine that is used to reduce pain, coughing, and diarrhea. The sap of the opium poppy, Papaver somniferum, contains it naturally. It is most commonly used to relieve mild to moderate pain. When coupled with paracetamol (acetaminophen) or a nonsteroidal anti-inflammatory medicine (NSAID) like aspirin or ibuprofen, a greater benefit may be obtained. Its use for acute cough suppression in children or adults is not supported by evidence. It's usually consumed by mouth. It usually begins to operate after half an hour and reaches its peak effect after two hours.
Report Objectives / Segmentation Covered
By Type
  • Tablets
  • Syrup
By Sales Channels
  • Direct Sales
  • In-Direct Sales

By End Users
  • Hospitals
  • Clinics

By Treatment
  • Pain
  • Cough
  • Diarrhea
  • Others

By Form
  • Tablets
  • Syrup

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Rise in Number of Cough and Body Pain Cases in Current Pandemic
    • 3.3. Market Challenges
      • 3.3.1. Side-Effects of Codeine Drugs
    • 3.4. Market Trends
      • 3.4.1. Leading Pharma Companies are Increasing Awareness Regarding Palliative Care Services
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Codeine Drug, by Type, Sales Channels, End Users, Treatment, Form and Region (value, volume and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Codeine Drug (Value)
      • 5.2.1. Global Codeine Drug by: Type (Value)
        • 5.2.1.1. Tablets
        • 5.2.1.2. Syrup
      • 5.2.2. Global Codeine Drug by: Sales Channels (Value)
        • 5.2.2.1. Direct Sales
        • 5.2.2.2. In-Direct Sales
      • 5.2.3. Global Codeine Drug by: End Users (Value)
        • 5.2.3.1. Hospitals
        • 5.2.3.2. Clinics
      • 5.2.4. Global Codeine Drug by: Treatment (Value)
        • 5.2.4.1. Pain
        • 5.2.4.2. Cough
        • 5.2.4.3. Diarrhea
        • 5.2.4.4. Others
      • 5.2.5. Global Codeine Drug by: Form (Value)
        • 5.2.5.1. Tablets
        • 5.2.5.2. Syrup
      • 5.2.6. Global Codeine Drug Region
        • 5.2.6.1. South America
          • 5.2.6.1.1. Brazil
          • 5.2.6.1.2. Argentina
          • 5.2.6.1.3. Rest of South America
        • 5.2.6.2. Asia Pacific
          • 5.2.6.2.1. China
          • 5.2.6.2.2. Japan
          • 5.2.6.2.3. India
          • 5.2.6.2.4. South Korea
          • 5.2.6.2.5. Taiwan
          • 5.2.6.2.6. Australia
          • 5.2.6.2.7. Rest of Asia-Pacific
        • 5.2.6.3. Europe
          • 5.2.6.3.1. Germany
          • 5.2.6.3.2. France
          • 5.2.6.3.3. Italy
          • 5.2.6.3.4. United Kingdom
          • 5.2.6.3.5. Netherlands
          • 5.2.6.3.6. Rest of Europe
        • 5.2.6.4. MEA
          • 5.2.6.4.1. Middle East
          • 5.2.6.4.2. Africa
        • 5.2.6.5. North America
          • 5.2.6.5.1. United States
          • 5.2.6.5.2. Canada
          • 5.2.6.5.3. Mexico
    • 5.3. Global Codeine Drug (Volume)
      • 5.3.1. Global Codeine Drug by: Type (Volume)
        • 5.3.1.1. Tablets
        • 5.3.1.2. Syrup
      • 5.3.2. Global Codeine Drug by: Sales Channels (Volume)
        • 5.3.2.1. Direct Sales
        • 5.3.2.2. In-Direct Sales
      • 5.3.3. Global Codeine Drug by: End Users (Volume)
        • 5.3.3.1. Hospitals
        • 5.3.3.2. Clinics
      • 5.3.4. Global Codeine Drug by: Treatment (Volume)
        • 5.3.4.1. Pain
        • 5.3.4.2. Cough
        • 5.3.4.3. Diarrhea
        • 5.3.4.4. Others
      • 5.3.5. Global Codeine Drug by: Form (Volume)
        • 5.3.5.1. Tablets
        • 5.3.5.2. Syrup
      • 5.3.6. Global Codeine Drug Region
        • 5.3.6.1. South America
          • 5.3.6.1.1. Brazil
          • 5.3.6.1.2. Argentina
          • 5.3.6.1.3. Rest of South America
        • 5.3.6.2. Asia Pacific
          • 5.3.6.2.1. China
          • 5.3.6.2.2. Japan
          • 5.3.6.2.3. India
          • 5.3.6.2.4. South Korea
          • 5.3.6.2.5. Taiwan
          • 5.3.6.2.6. Australia
          • 5.3.6.2.7. Rest of Asia-Pacific
        • 5.3.6.3. Europe
          • 5.3.6.3.1. Germany
          • 5.3.6.3.2. France
          • 5.3.6.3.3. Italy
          • 5.3.6.3.4. United Kingdom
          • 5.3.6.3.5. Netherlands
          • 5.3.6.3.6. Rest of Europe
        • 5.3.6.4. MEA
          • 5.3.6.4.1. Middle East
          • 5.3.6.4.2. Africa
        • 5.3.6.5. North America
          • 5.3.6.5.1. United States
          • 5.3.6.5.2. Canada
          • 5.3.6.5.3. Mexico
    • 5.4. Global Codeine Drug (Price)
      • 5.4.1. Global Codeine Drug by: Type (Price)
  • 6. Codeine Drug: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Pfizer (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. Abbott (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Merck (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Sanofi (France)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Johnson and Johnson (United States)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Janssen Pharmaceuticals (Belgium)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Mallinckrodt Pharmaceuticals (United Kingdom)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. Endo Pharmaceuticals (Ireland)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Assertio Therapeutics (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. Sun Pharma (India)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Codeine Drug Sale, by Type, Sales Channels, End Users, Treatment, Form and Region (value, volume and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Codeine Drug (Value)
      • 7.2.1. Global Codeine Drug by: Type (Value)
        • 7.2.1.1. Tablets
        • 7.2.1.2. Syrup
      • 7.2.2. Global Codeine Drug by: Sales Channels (Value)
        • 7.2.2.1. Direct Sales
        • 7.2.2.2. In-Direct Sales
      • 7.2.3. Global Codeine Drug by: End Users (Value)
        • 7.2.3.1. Hospitals
        • 7.2.3.2. Clinics
      • 7.2.4. Global Codeine Drug by: Treatment (Value)
        • 7.2.4.1. Pain
        • 7.2.4.2. Cough
        • 7.2.4.3. Diarrhea
        • 7.2.4.4. Others
      • 7.2.5. Global Codeine Drug by: Form (Value)
        • 7.2.5.1. Tablets
        • 7.2.5.2. Syrup
      • 7.2.6. Global Codeine Drug Region
        • 7.2.6.1. South America
          • 7.2.6.1.1. Brazil
          • 7.2.6.1.2. Argentina
          • 7.2.6.1.3. Rest of South America
        • 7.2.6.2. Asia Pacific
          • 7.2.6.2.1. China
          • 7.2.6.2.2. Japan
          • 7.2.6.2.3. India
          • 7.2.6.2.4. South Korea
          • 7.2.6.2.5. Taiwan
          • 7.2.6.2.6. Australia
          • 7.2.6.2.7. Rest of Asia-Pacific
        • 7.2.6.3. Europe
          • 7.2.6.3.1. Germany
          • 7.2.6.3.2. France
          • 7.2.6.3.3. Italy
          • 7.2.6.3.4. United Kingdom
          • 7.2.6.3.5. Netherlands
          • 7.2.6.3.6. Rest of Europe
        • 7.2.6.4. MEA
          • 7.2.6.4.1. Middle East
          • 7.2.6.4.2. Africa
        • 7.2.6.5. North America
          • 7.2.6.5.1. United States
          • 7.2.6.5.2. Canada
          • 7.2.6.5.3. Mexico
    • 7.3. Global Codeine Drug (Volume)
      • 7.3.1. Global Codeine Drug by: Type (Volume)
        • 7.3.1.1. Tablets
        • 7.3.1.2. Syrup
      • 7.3.2. Global Codeine Drug by: Sales Channels (Volume)
        • 7.3.2.1. Direct Sales
        • 7.3.2.2. In-Direct Sales
      • 7.3.3. Global Codeine Drug by: End Users (Volume)
        • 7.3.3.1. Hospitals
        • 7.3.3.2. Clinics
      • 7.3.4. Global Codeine Drug by: Treatment (Volume)
        • 7.3.4.1. Pain
        • 7.3.4.2. Cough
        • 7.3.4.3. Diarrhea
        • 7.3.4.4. Others
      • 7.3.5. Global Codeine Drug by: Form (Volume)
        • 7.3.5.1. Tablets
        • 7.3.5.2. Syrup
      • 7.3.6. Global Codeine Drug Region
        • 7.3.6.1. South America
          • 7.3.6.1.1. Brazil
          • 7.3.6.1.2. Argentina
          • 7.3.6.1.3. Rest of South America
        • 7.3.6.2. Asia Pacific
          • 7.3.6.2.1. China
          • 7.3.6.2.2. Japan
          • 7.3.6.2.3. India
          • 7.3.6.2.4. South Korea
          • 7.3.6.2.5. Taiwan
          • 7.3.6.2.6. Australia
          • 7.3.6.2.7. Rest of Asia-Pacific
        • 7.3.6.3. Europe
          • 7.3.6.3.1. Germany
          • 7.3.6.3.2. France
          • 7.3.6.3.3. Italy
          • 7.3.6.3.4. United Kingdom
          • 7.3.6.3.5. Netherlands
          • 7.3.6.3.6. Rest of Europe
        • 7.3.6.4. MEA
          • 7.3.6.4.1. Middle East
          • 7.3.6.4.2. Africa
        • 7.3.6.5. North America
          • 7.3.6.5.1. United States
          • 7.3.6.5.2. Canada
          • 7.3.6.5.3. Mexico
    • 7.4. Global Codeine Drug (Price)
      • 7.4.1. Global Codeine Drug by: Type (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Codeine Drug: by Type(USD Million)
  • Table 2. Codeine Drug Tablets , by Region USD Million (2015-2020)
  • Table 3. Codeine Drug Syrup , by Region USD Million (2015-2020)
  • Table 4. Codeine Drug: by Sales Channels(USD Million)
  • Table 5. Codeine Drug Direct Sales , by Region USD Million (2015-2020)
  • Table 6. Codeine Drug In-Direct Sales , by Region USD Million (2015-2020)
  • Table 7. Codeine Drug: by End Users(USD Million)
  • Table 8. Codeine Drug Hospitals , by Region USD Million (2015-2020)
  • Table 9. Codeine Drug Clinics , by Region USD Million (2015-2020)
  • Table 10. Codeine Drug: by Treatment(USD Million)
  • Table 11. Codeine Drug Pain , by Region USD Million (2015-2020)
  • Table 12. Codeine Drug Cough , by Region USD Million (2015-2020)
  • Table 13. Codeine Drug Diarrhea , by Region USD Million (2015-2020)
  • Table 14. Codeine Drug Others , by Region USD Million (2015-2020)
  • Table 15. Codeine Drug: by Form(USD Million)
  • Table 16. Codeine Drug Tablets , by Region USD Million (2015-2020)
  • Table 17. Codeine Drug Syrup , by Region USD Million (2015-2020)
  • Table 18. South America Codeine Drug, by Country USD Million (2015-2020)
  • Table 19. South America Codeine Drug, by Type USD Million (2015-2020)
  • Table 20. South America Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 21. South America Codeine Drug, by End Users USD Million (2015-2020)
  • Table 22. South America Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 23. South America Codeine Drug, by Form USD Million (2015-2020)
  • Table 24. Brazil Codeine Drug, by Type USD Million (2015-2020)
  • Table 25. Brazil Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 26. Brazil Codeine Drug, by End Users USD Million (2015-2020)
  • Table 27. Brazil Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 28. Brazil Codeine Drug, by Form USD Million (2015-2020)
  • Table 29. Argentina Codeine Drug, by Type USD Million (2015-2020)
  • Table 30. Argentina Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 31. Argentina Codeine Drug, by End Users USD Million (2015-2020)
  • Table 32. Argentina Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 33. Argentina Codeine Drug, by Form USD Million (2015-2020)
  • Table 34. Rest of South America Codeine Drug, by Type USD Million (2015-2020)
  • Table 35. Rest of South America Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 36. Rest of South America Codeine Drug, by End Users USD Million (2015-2020)
  • Table 37. Rest of South America Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 38. Rest of South America Codeine Drug, by Form USD Million (2015-2020)
  • Table 39. Asia Pacific Codeine Drug, by Country USD Million (2015-2020)
  • Table 40. Asia Pacific Codeine Drug, by Type USD Million (2015-2020)
  • Table 41. Asia Pacific Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 42. Asia Pacific Codeine Drug, by End Users USD Million (2015-2020)
  • Table 43. Asia Pacific Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 44. Asia Pacific Codeine Drug, by Form USD Million (2015-2020)
  • Table 45. China Codeine Drug, by Type USD Million (2015-2020)
  • Table 46. China Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 47. China Codeine Drug, by End Users USD Million (2015-2020)
  • Table 48. China Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 49. China Codeine Drug, by Form USD Million (2015-2020)
  • Table 50. Japan Codeine Drug, by Type USD Million (2015-2020)
  • Table 51. Japan Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 52. Japan Codeine Drug, by End Users USD Million (2015-2020)
  • Table 53. Japan Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 54. Japan Codeine Drug, by Form USD Million (2015-2020)
  • Table 55. India Codeine Drug, by Type USD Million (2015-2020)
  • Table 56. India Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 57. India Codeine Drug, by End Users USD Million (2015-2020)
  • Table 58. India Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 59. India Codeine Drug, by Form USD Million (2015-2020)
  • Table 60. South Korea Codeine Drug, by Type USD Million (2015-2020)
  • Table 61. South Korea Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 62. South Korea Codeine Drug, by End Users USD Million (2015-2020)
  • Table 63. South Korea Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 64. South Korea Codeine Drug, by Form USD Million (2015-2020)
  • Table 65. Taiwan Codeine Drug, by Type USD Million (2015-2020)
  • Table 66. Taiwan Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 67. Taiwan Codeine Drug, by End Users USD Million (2015-2020)
  • Table 68. Taiwan Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 69. Taiwan Codeine Drug, by Form USD Million (2015-2020)
  • Table 70. Australia Codeine Drug, by Type USD Million (2015-2020)
  • Table 71. Australia Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 72. Australia Codeine Drug, by End Users USD Million (2015-2020)
  • Table 73. Australia Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 74. Australia Codeine Drug, by Form USD Million (2015-2020)
  • Table 75. Rest of Asia-Pacific Codeine Drug, by Type USD Million (2015-2020)
  • Table 76. Rest of Asia-Pacific Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 77. Rest of Asia-Pacific Codeine Drug, by End Users USD Million (2015-2020)
  • Table 78. Rest of Asia-Pacific Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 79. Rest of Asia-Pacific Codeine Drug, by Form USD Million (2015-2020)
  • Table 80. Europe Codeine Drug, by Country USD Million (2015-2020)
  • Table 81. Europe Codeine Drug, by Type USD Million (2015-2020)
  • Table 82. Europe Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 83. Europe Codeine Drug, by End Users USD Million (2015-2020)
  • Table 84. Europe Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 85. Europe Codeine Drug, by Form USD Million (2015-2020)
  • Table 86. Germany Codeine Drug, by Type USD Million (2015-2020)
  • Table 87. Germany Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 88. Germany Codeine Drug, by End Users USD Million (2015-2020)
  • Table 89. Germany Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 90. Germany Codeine Drug, by Form USD Million (2015-2020)
  • Table 91. France Codeine Drug, by Type USD Million (2015-2020)
  • Table 92. France Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 93. France Codeine Drug, by End Users USD Million (2015-2020)
  • Table 94. France Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 95. France Codeine Drug, by Form USD Million (2015-2020)
  • Table 96. Italy Codeine Drug, by Type USD Million (2015-2020)
  • Table 97. Italy Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 98. Italy Codeine Drug, by End Users USD Million (2015-2020)
  • Table 99. Italy Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 100. Italy Codeine Drug, by Form USD Million (2015-2020)
  • Table 101. United Kingdom Codeine Drug, by Type USD Million (2015-2020)
  • Table 102. United Kingdom Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 103. United Kingdom Codeine Drug, by End Users USD Million (2015-2020)
  • Table 104. United Kingdom Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 105. United Kingdom Codeine Drug, by Form USD Million (2015-2020)
  • Table 106. Netherlands Codeine Drug, by Type USD Million (2015-2020)
  • Table 107. Netherlands Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 108. Netherlands Codeine Drug, by End Users USD Million (2015-2020)
  • Table 109. Netherlands Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 110. Netherlands Codeine Drug, by Form USD Million (2015-2020)
  • Table 111. Rest of Europe Codeine Drug, by Type USD Million (2015-2020)
  • Table 112. Rest of Europe Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 113. Rest of Europe Codeine Drug, by End Users USD Million (2015-2020)
  • Table 114. Rest of Europe Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 115. Rest of Europe Codeine Drug, by Form USD Million (2015-2020)
  • Table 116. MEA Codeine Drug, by Country USD Million (2015-2020)
  • Table 117. MEA Codeine Drug, by Type USD Million (2015-2020)
  • Table 118. MEA Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 119. MEA Codeine Drug, by End Users USD Million (2015-2020)
  • Table 120. MEA Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 121. MEA Codeine Drug, by Form USD Million (2015-2020)
  • Table 122. Middle East Codeine Drug, by Type USD Million (2015-2020)
  • Table 123. Middle East Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 124. Middle East Codeine Drug, by End Users USD Million (2015-2020)
  • Table 125. Middle East Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 126. Middle East Codeine Drug, by Form USD Million (2015-2020)
  • Table 127. Africa Codeine Drug, by Type USD Million (2015-2020)
  • Table 128. Africa Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 129. Africa Codeine Drug, by End Users USD Million (2015-2020)
  • Table 130. Africa Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 131. Africa Codeine Drug, by Form USD Million (2015-2020)
  • Table 132. North America Codeine Drug, by Country USD Million (2015-2020)
  • Table 133. North America Codeine Drug, by Type USD Million (2015-2020)
  • Table 134. North America Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 135. North America Codeine Drug, by End Users USD Million (2015-2020)
  • Table 136. North America Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 137. North America Codeine Drug, by Form USD Million (2015-2020)
  • Table 138. United States Codeine Drug, by Type USD Million (2015-2020)
  • Table 139. United States Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 140. United States Codeine Drug, by End Users USD Million (2015-2020)
  • Table 141. United States Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 142. United States Codeine Drug, by Form USD Million (2015-2020)
  • Table 143. Canada Codeine Drug, by Type USD Million (2015-2020)
  • Table 144. Canada Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 145. Canada Codeine Drug, by End Users USD Million (2015-2020)
  • Table 146. Canada Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 147. Canada Codeine Drug, by Form USD Million (2015-2020)
  • Table 148. Mexico Codeine Drug, by Type USD Million (2015-2020)
  • Table 149. Mexico Codeine Drug, by Sales Channels USD Million (2015-2020)
  • Table 150. Mexico Codeine Drug, by End Users USD Million (2015-2020)
  • Table 151. Mexico Codeine Drug, by Treatment USD Million (2015-2020)
  • Table 152. Mexico Codeine Drug, by Form USD Million (2015-2020)
  • Table 153. Codeine Drug Sales: by Type(K Tons)
  • Table 154. Codeine Drug Sales Tablets , by Region K Tons (2015-2020)
  • Table 155. Codeine Drug Sales Syrup , by Region K Tons (2015-2020)
  • Table 156. Codeine Drug Sales: by Sales Channels(K Tons)
  • Table 157. Codeine Drug Sales Direct Sales , by Region K Tons (2015-2020)
  • Table 158. Codeine Drug Sales In-Direct Sales , by Region K Tons (2015-2020)
  • Table 159. Codeine Drug Sales: by End Users(K Tons)
  • Table 160. Codeine Drug Sales Hospitals , by Region K Tons (2015-2020)
  • Table 161. Codeine Drug Sales Clinics , by Region K Tons (2015-2020)
  • Table 162. Codeine Drug Sales: by Treatment(K Tons)
  • Table 163. Codeine Drug Sales Pain , by Region K Tons (2015-2020)
  • Table 164. Codeine Drug Sales Cough , by Region K Tons (2015-2020)
  • Table 165. Codeine Drug Sales Diarrhea , by Region K Tons (2015-2020)
  • Table 166. Codeine Drug Sales Others , by Region K Tons (2015-2020)
  • Table 167. Codeine Drug Sales: by Form(K Tons)
  • Table 168. Codeine Drug Sales Tablets , by Region K Tons (2015-2020)
  • Table 169. Codeine Drug Sales Syrup , by Region K Tons (2015-2020)
  • Table 170. South America Codeine Drug Sales, by Country K Tons (2015-2020)
  • Table 171. South America Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 172. South America Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 173. South America Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 174. South America Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 175. South America Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 176. Brazil Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 177. Brazil Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 178. Brazil Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 179. Brazil Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 180. Brazil Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 181. Argentina Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 182. Argentina Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 183. Argentina Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 184. Argentina Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 185. Argentina Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 186. Rest of South America Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 187. Rest of South America Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 188. Rest of South America Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 189. Rest of South America Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 190. Rest of South America Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 191. Asia Pacific Codeine Drug Sales, by Country K Tons (2015-2020)
  • Table 192. Asia Pacific Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 193. Asia Pacific Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 194. Asia Pacific Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 195. Asia Pacific Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 196. Asia Pacific Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 197. China Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 198. China Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 199. China Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 200. China Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 201. China Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 202. Japan Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 203. Japan Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 204. Japan Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 205. Japan Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 206. Japan Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 207. India Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 208. India Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 209. India Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 210. India Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 211. India Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 212. South Korea Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 213. South Korea Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 214. South Korea Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 215. South Korea Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 216. South Korea Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 217. Taiwan Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 218. Taiwan Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 219. Taiwan Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 220. Taiwan Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 221. Taiwan Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 222. Australia Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 223. Australia Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 224. Australia Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 225. Australia Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 226. Australia Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 227. Rest of Asia-Pacific Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 228. Rest of Asia-Pacific Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 229. Rest of Asia-Pacific Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 230. Rest of Asia-Pacific Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 231. Rest of Asia-Pacific Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 232. Europe Codeine Drug Sales, by Country K Tons (2015-2020)
  • Table 233. Europe Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 234. Europe Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 235. Europe Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 236. Europe Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 237. Europe Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 238. Germany Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 239. Germany Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 240. Germany Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 241. Germany Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 242. Germany Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 243. France Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 244. France Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 245. France Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 246. France Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 247. France Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 248. Italy Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 249. Italy Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 250. Italy Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 251. Italy Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 252. Italy Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 253. United Kingdom Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 254. United Kingdom Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 255. United Kingdom Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 256. United Kingdom Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 257. United Kingdom Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 258. Netherlands Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 259. Netherlands Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 260. Netherlands Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 261. Netherlands Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 262. Netherlands Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 263. Rest of Europe Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 264. Rest of Europe Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 265. Rest of Europe Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 266. Rest of Europe Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 267. Rest of Europe Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 268. MEA Codeine Drug Sales, by Country K Tons (2015-2020)
  • Table 269. MEA Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 270. MEA Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 271. MEA Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 272. MEA Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 273. MEA Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 274. Middle East Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 275. Middle East Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 276. Middle East Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 277. Middle East Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 278. Middle East Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 279. Africa Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 280. Africa Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 281. Africa Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 282. Africa Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 283. Africa Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 284. North America Codeine Drug Sales, by Country K Tons (2015-2020)
  • Table 285. North America Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 286. North America Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 287. North America Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 288. North America Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 289. North America Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 290. United States Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 291. United States Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 292. United States Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 293. United States Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 294. United States Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 295. Canada Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 296. Canada Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 297. Canada Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 298. Canada Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 299. Canada Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 300. Mexico Codeine Drug Sales, by Type K Tons (2015-2020)
  • Table 301. Mexico Codeine Drug Sales, by Sales Channels K Tons (2015-2020)
  • Table 302. Mexico Codeine Drug Sales, by End Users K Tons (2015-2020)
  • Table 303. Mexico Codeine Drug Sales, by Treatment K Tons (2015-2020)
  • Table 304. Mexico Codeine Drug Sales, by Form K Tons (2015-2020)
  • Table 305. Codeine Drug: by Type(USD/Units)
  • Table 306. Company Basic Information, Sales Area and Its Competitors
  • Table 307. Company Basic Information, Sales Area and Its Competitors
  • Table 308. Company Basic Information, Sales Area and Its Competitors
  • Table 309. Company Basic Information, Sales Area and Its Competitors
  • Table 310. Company Basic Information, Sales Area and Its Competitors
  • Table 311. Company Basic Information, Sales Area and Its Competitors
  • Table 312. Company Basic Information, Sales Area and Its Competitors
  • Table 313. Company Basic Information, Sales Area and Its Competitors
  • Table 314. Company Basic Information, Sales Area and Its Competitors
  • Table 315. Company Basic Information, Sales Area and Its Competitors
  • Table 316. Codeine Drug: by Type(USD Million)
  • Table 317. Codeine Drug Tablets , by Region USD Million (2021-2026)
  • Table 318. Codeine Drug Syrup , by Region USD Million (2021-2026)
  • Table 319. Codeine Drug: by Sales Channels(USD Million)
  • Table 320. Codeine Drug Direct Sales , by Region USD Million (2021-2026)
  • Table 321. Codeine Drug In-Direct Sales , by Region USD Million (2021-2026)
  • Table 322. Codeine Drug: by End Users(USD Million)
  • Table 323. Codeine Drug Hospitals , by Region USD Million (2021-2026)
  • Table 324. Codeine Drug Clinics , by Region USD Million (2021-2026)
  • Table 325. Codeine Drug: by Treatment(USD Million)
  • Table 326. Codeine Drug Pain , by Region USD Million (2021-2026)
  • Table 327. Codeine Drug Cough , by Region USD Million (2021-2026)
  • Table 328. Codeine Drug Diarrhea , by Region USD Million (2021-2026)
  • Table 329. Codeine Drug Others , by Region USD Million (2021-2026)
  • Table 330. Codeine Drug: by Form(USD Million)
  • Table 331. Codeine Drug Tablets , by Region USD Million (2021-2026)
  • Table 332. Codeine Drug Syrup , by Region USD Million (2021-2026)
  • Table 333. South America Codeine Drug, by Country USD Million (2021-2026)
  • Table 334. South America Codeine Drug, by Type USD Million (2021-2026)
  • Table 335. South America Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 336. South America Codeine Drug, by End Users USD Million (2021-2026)
  • Table 337. South America Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 338. South America Codeine Drug, by Form USD Million (2021-2026)
  • Table 339. Brazil Codeine Drug, by Type USD Million (2021-2026)
  • Table 340. Brazil Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 341. Brazil Codeine Drug, by End Users USD Million (2021-2026)
  • Table 342. Brazil Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 343. Brazil Codeine Drug, by Form USD Million (2021-2026)
  • Table 344. Argentina Codeine Drug, by Type USD Million (2021-2026)
  • Table 345. Argentina Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 346. Argentina Codeine Drug, by End Users USD Million (2021-2026)
  • Table 347. Argentina Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 348. Argentina Codeine Drug, by Form USD Million (2021-2026)
  • Table 349. Rest of South America Codeine Drug, by Type USD Million (2021-2026)
  • Table 350. Rest of South America Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 351. Rest of South America Codeine Drug, by End Users USD Million (2021-2026)
  • Table 352. Rest of South America Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 353. Rest of South America Codeine Drug, by Form USD Million (2021-2026)
  • Table 354. Asia Pacific Codeine Drug, by Country USD Million (2021-2026)
  • Table 355. Asia Pacific Codeine Drug, by Type USD Million (2021-2026)
  • Table 356. Asia Pacific Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 357. Asia Pacific Codeine Drug, by End Users USD Million (2021-2026)
  • Table 358. Asia Pacific Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 359. Asia Pacific Codeine Drug, by Form USD Million (2021-2026)
  • Table 360. China Codeine Drug, by Type USD Million (2021-2026)
  • Table 361. China Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 362. China Codeine Drug, by End Users USD Million (2021-2026)
  • Table 363. China Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 364. China Codeine Drug, by Form USD Million (2021-2026)
  • Table 365. Japan Codeine Drug, by Type USD Million (2021-2026)
  • Table 366. Japan Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 367. Japan Codeine Drug, by End Users USD Million (2021-2026)
  • Table 368. Japan Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 369. Japan Codeine Drug, by Form USD Million (2021-2026)
  • Table 370. India Codeine Drug, by Type USD Million (2021-2026)
  • Table 371. India Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 372. India Codeine Drug, by End Users USD Million (2021-2026)
  • Table 373. India Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 374. India Codeine Drug, by Form USD Million (2021-2026)
  • Table 375. South Korea Codeine Drug, by Type USD Million (2021-2026)
  • Table 376. South Korea Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 377. South Korea Codeine Drug, by End Users USD Million (2021-2026)
  • Table 378. South Korea Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 379. South Korea Codeine Drug, by Form USD Million (2021-2026)
  • Table 380. Taiwan Codeine Drug, by Type USD Million (2021-2026)
  • Table 381. Taiwan Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 382. Taiwan Codeine Drug, by End Users USD Million (2021-2026)
  • Table 383. Taiwan Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 384. Taiwan Codeine Drug, by Form USD Million (2021-2026)
  • Table 385. Australia Codeine Drug, by Type USD Million (2021-2026)
  • Table 386. Australia Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 387. Australia Codeine Drug, by End Users USD Million (2021-2026)
  • Table 388. Australia Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 389. Australia Codeine Drug, by Form USD Million (2021-2026)
  • Table 390. Rest of Asia-Pacific Codeine Drug, by Type USD Million (2021-2026)
  • Table 391. Rest of Asia-Pacific Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 392. Rest of Asia-Pacific Codeine Drug, by End Users USD Million (2021-2026)
  • Table 393. Rest of Asia-Pacific Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 394. Rest of Asia-Pacific Codeine Drug, by Form USD Million (2021-2026)
  • Table 395. Europe Codeine Drug, by Country USD Million (2021-2026)
  • Table 396. Europe Codeine Drug, by Type USD Million (2021-2026)
  • Table 397. Europe Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 398. Europe Codeine Drug, by End Users USD Million (2021-2026)
  • Table 399. Europe Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 400. Europe Codeine Drug, by Form USD Million (2021-2026)
  • Table 401. Germany Codeine Drug, by Type USD Million (2021-2026)
  • Table 402. Germany Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 403. Germany Codeine Drug, by End Users USD Million (2021-2026)
  • Table 404. Germany Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 405. Germany Codeine Drug, by Form USD Million (2021-2026)
  • Table 406. France Codeine Drug, by Type USD Million (2021-2026)
  • Table 407. France Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 408. France Codeine Drug, by End Users USD Million (2021-2026)
  • Table 409. France Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 410. France Codeine Drug, by Form USD Million (2021-2026)
  • Table 411. Italy Codeine Drug, by Type USD Million (2021-2026)
  • Table 412. Italy Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 413. Italy Codeine Drug, by End Users USD Million (2021-2026)
  • Table 414. Italy Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 415. Italy Codeine Drug, by Form USD Million (2021-2026)
  • Table 416. United Kingdom Codeine Drug, by Type USD Million (2021-2026)
  • Table 417. United Kingdom Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 418. United Kingdom Codeine Drug, by End Users USD Million (2021-2026)
  • Table 419. United Kingdom Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 420. United Kingdom Codeine Drug, by Form USD Million (2021-2026)
  • Table 421. Netherlands Codeine Drug, by Type USD Million (2021-2026)
  • Table 422. Netherlands Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 423. Netherlands Codeine Drug, by End Users USD Million (2021-2026)
  • Table 424. Netherlands Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 425. Netherlands Codeine Drug, by Form USD Million (2021-2026)
  • Table 426. Rest of Europe Codeine Drug, by Type USD Million (2021-2026)
  • Table 427. Rest of Europe Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 428. Rest of Europe Codeine Drug, by End Users USD Million (2021-2026)
  • Table 429. Rest of Europe Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 430. Rest of Europe Codeine Drug, by Form USD Million (2021-2026)
  • Table 431. MEA Codeine Drug, by Country USD Million (2021-2026)
  • Table 432. MEA Codeine Drug, by Type USD Million (2021-2026)
  • Table 433. MEA Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 434. MEA Codeine Drug, by End Users USD Million (2021-2026)
  • Table 435. MEA Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 436. MEA Codeine Drug, by Form USD Million (2021-2026)
  • Table 437. Middle East Codeine Drug, by Type USD Million (2021-2026)
  • Table 438. Middle East Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 439. Middle East Codeine Drug, by End Users USD Million (2021-2026)
  • Table 440. Middle East Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 441. Middle East Codeine Drug, by Form USD Million (2021-2026)
  • Table 442. Africa Codeine Drug, by Type USD Million (2021-2026)
  • Table 443. Africa Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 444. Africa Codeine Drug, by End Users USD Million (2021-2026)
  • Table 445. Africa Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 446. Africa Codeine Drug, by Form USD Million (2021-2026)
  • Table 447. North America Codeine Drug, by Country USD Million (2021-2026)
  • Table 448. North America Codeine Drug, by Type USD Million (2021-2026)
  • Table 449. North America Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 450. North America Codeine Drug, by End Users USD Million (2021-2026)
  • Table 451. North America Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 452. North America Codeine Drug, by Form USD Million (2021-2026)
  • Table 453. United States Codeine Drug, by Type USD Million (2021-2026)
  • Table 454. United States Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 455. United States Codeine Drug, by End Users USD Million (2021-2026)
  • Table 456. United States Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 457. United States Codeine Drug, by Form USD Million (2021-2026)
  • Table 458. Canada Codeine Drug, by Type USD Million (2021-2026)
  • Table 459. Canada Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 460. Canada Codeine Drug, by End Users USD Million (2021-2026)
  • Table 461. Canada Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 462. Canada Codeine Drug, by Form USD Million (2021-2026)
  • Table 463. Mexico Codeine Drug, by Type USD Million (2021-2026)
  • Table 464. Mexico Codeine Drug, by Sales Channels USD Million (2021-2026)
  • Table 465. Mexico Codeine Drug, by End Users USD Million (2021-2026)
  • Table 466. Mexico Codeine Drug, by Treatment USD Million (2021-2026)
  • Table 467. Mexico Codeine Drug, by Form USD Million (2021-2026)
  • Table 468. Codeine Drug Sales: by Type(K Tons)
  • Table 469. Codeine Drug Sales Tablets , by Region K Tons (2021-2026)
  • Table 470. Codeine Drug Sales Syrup , by Region K Tons (2021-2026)
  • Table 471. Codeine Drug Sales: by Sales Channels(K Tons)
  • Table 472. Codeine Drug Sales Direct Sales , by Region K Tons (2021-2026)
  • Table 473. Codeine Drug Sales In-Direct Sales , by Region K Tons (2021-2026)
  • Table 474. Codeine Drug Sales: by End Users(K Tons)
  • Table 475. Codeine Drug Sales Hospitals , by Region K Tons (2021-2026)
  • Table 476. Codeine Drug Sales Clinics , by Region K Tons (2021-2026)
  • Table 477. Codeine Drug Sales: by Treatment(K Tons)
  • Table 478. Codeine Drug Sales Pain , by Region K Tons (2021-2026)
  • Table 479. Codeine Drug Sales Cough , by Region K Tons (2021-2026)
  • Table 480. Codeine Drug Sales Diarrhea , by Region K Tons (2021-2026)
  • Table 481. Codeine Drug Sales Others , by Region K Tons (2021-2026)
  • Table 482. Codeine Drug Sales: by Form(K Tons)
  • Table 483. Codeine Drug Sales Tablets , by Region K Tons (2021-2026)
  • Table 484. Codeine Drug Sales Syrup , by Region K Tons (2021-2026)
  • Table 485. South America Codeine Drug Sales, by Country K Tons (2021-2026)
  • Table 486. South America Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 487. South America Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 488. South America Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 489. South America Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 490. South America Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 491. Brazil Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 492. Brazil Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 493. Brazil Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 494. Brazil Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 495. Brazil Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 496. Argentina Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 497. Argentina Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 498. Argentina Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 499. Argentina Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 500. Argentina Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 501. Rest of South America Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 502. Rest of South America Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 503. Rest of South America Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 504. Rest of South America Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 505. Rest of South America Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 506. Asia Pacific Codeine Drug Sales, by Country K Tons (2021-2026)
  • Table 507. Asia Pacific Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 508. Asia Pacific Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 509. Asia Pacific Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 510. Asia Pacific Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 511. Asia Pacific Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 512. China Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 513. China Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 514. China Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 515. China Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 516. China Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 517. Japan Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 518. Japan Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 519. Japan Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 520. Japan Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 521. Japan Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 522. India Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 523. India Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 524. India Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 525. India Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 526. India Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 527. South Korea Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 528. South Korea Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 529. South Korea Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 530. South Korea Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 531. South Korea Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 532. Taiwan Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 533. Taiwan Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 534. Taiwan Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 535. Taiwan Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 536. Taiwan Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 537. Australia Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 538. Australia Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 539. Australia Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 540. Australia Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 541. Australia Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 542. Rest of Asia-Pacific Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 543. Rest of Asia-Pacific Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 544. Rest of Asia-Pacific Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 545. Rest of Asia-Pacific Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 546. Rest of Asia-Pacific Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 547. Europe Codeine Drug Sales, by Country K Tons (2021-2026)
  • Table 548. Europe Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 549. Europe Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 550. Europe Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 551. Europe Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 552. Europe Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 553. Germany Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 554. Germany Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 555. Germany Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 556. Germany Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 557. Germany Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 558. France Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 559. France Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 560. France Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 561. France Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 562. France Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 563. Italy Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 564. Italy Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 565. Italy Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 566. Italy Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 567. Italy Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 568. United Kingdom Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 569. United Kingdom Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 570. United Kingdom Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 571. United Kingdom Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 572. United Kingdom Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 573. Netherlands Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 574. Netherlands Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 575. Netherlands Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 576. Netherlands Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 577. Netherlands Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 578. Rest of Europe Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 579. Rest of Europe Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 580. Rest of Europe Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 581. Rest of Europe Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 582. Rest of Europe Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 583. MEA Codeine Drug Sales, by Country K Tons (2021-2026)
  • Table 584. MEA Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 585. MEA Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 586. MEA Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 587. MEA Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 588. MEA Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 589. Middle East Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 590. Middle East Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 591. Middle East Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 592. Middle East Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 593. Middle East Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 594. Africa Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 595. Africa Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 596. Africa Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 597. Africa Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 598. Africa Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 599. North America Codeine Drug Sales, by Country K Tons (2021-2026)
  • Table 600. North America Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 601. North America Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 602. North America Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 603. North America Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 604. North America Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 605. United States Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 606. United States Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 607. United States Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 608. United States Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 609. United States Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 610. Canada Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 611. Canada Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 612. Canada Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 613. Canada Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 614. Canada Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 615. Mexico Codeine Drug Sales, by Type K Tons (2021-2026)
  • Table 616. Mexico Codeine Drug Sales, by Sales Channels K Tons (2021-2026)
  • Table 617. Mexico Codeine Drug Sales, by End Users K Tons (2021-2026)
  • Table 618. Mexico Codeine Drug Sales, by Treatment K Tons (2021-2026)
  • Table 619. Mexico Codeine Drug Sales, by Form K Tons (2021-2026)
  • Table 620. Codeine Drug: by Type(USD/Units)
  • Table 621. Research Programs/Design for This Report
  • Table 622. Key Data Information from Secondary Sources
  • Table 623. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Codeine Drug: by Type USD Million (2015-2020)
  • Figure 5. Global Codeine Drug: by Sales Channels USD Million (2015-2020)
  • Figure 6. Global Codeine Drug: by End Users USD Million (2015-2020)
  • Figure 7. Global Codeine Drug: by Treatment USD Million (2015-2020)
  • Figure 8. Global Codeine Drug: by Form USD Million (2015-2020)
  • Figure 9. South America Codeine Drug Share (%), by Country
  • Figure 10. Asia Pacific Codeine Drug Share (%), by Country
  • Figure 11. Europe Codeine Drug Share (%), by Country
  • Figure 12. MEA Codeine Drug Share (%), by Country
  • Figure 13. North America Codeine Drug Share (%), by Country
  • Figure 14. Global Codeine Drug: by Type K Tons (2015-2020)
  • Figure 15. Global Codeine Drug: by Sales Channels K Tons (2015-2020)
  • Figure 16. Global Codeine Drug: by End Users K Tons (2015-2020)
  • Figure 17. Global Codeine Drug: by Treatment K Tons (2015-2020)
  • Figure 18. Global Codeine Drug: by Form K Tons (2015-2020)
  • Figure 19. South America Codeine Drug Share (%), by Country
  • Figure 20. Asia Pacific Codeine Drug Share (%), by Country
  • Figure 21. Europe Codeine Drug Share (%), by Country
  • Figure 22. MEA Codeine Drug Share (%), by Country
  • Figure 23. North America Codeine Drug Share (%), by Country
  • Figure 24. Global Codeine Drug: by Type USD/Units (2015-2020)
  • Figure 25. Global Codeine Drug share by Players 2020 (%)
  • Figure 26. Global Codeine Drug share by Players (Top 3) 2020(%)
  • Figure 27. Global Codeine Drug share by Players (Top 5) 2020(%)
  • Figure 28. BCG Matrix for key Companies
  • Figure 29. Pfizer (United States) Revenue, Net Income and Gross profit
  • Figure 30. Pfizer (United States) Revenue: by Geography 2020
  • Figure 31. Abbott (United States) Revenue, Net Income and Gross profit
  • Figure 32. Abbott (United States) Revenue: by Geography 2020
  • Figure 33. Merck (United States) Revenue, Net Income and Gross profit
  • Figure 34. Merck (United States) Revenue: by Geography 2020
  • Figure 35. Sanofi (France) Revenue, Net Income and Gross profit
  • Figure 36. Sanofi (France) Revenue: by Geography 2020
  • Figure 37. Johnson and Johnson (United States) Revenue, Net Income and Gross profit
  • Figure 38. Johnson and Johnson (United States) Revenue: by Geography 2020
  • Figure 39. Janssen Pharmaceuticals (Belgium) Revenue, Net Income and Gross profit
  • Figure 40. Janssen Pharmaceuticals (Belgium) Revenue: by Geography 2020
  • Figure 41. Mallinckrodt Pharmaceuticals (United Kingdom) Revenue, Net Income and Gross profit
  • Figure 42. Mallinckrodt Pharmaceuticals (United Kingdom) Revenue: by Geography 2020
  • Figure 43. Endo Pharmaceuticals (Ireland) Revenue, Net Income and Gross profit
  • Figure 44. Endo Pharmaceuticals (Ireland) Revenue: by Geography 2020
  • Figure 45. Assertio Therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 46. Assertio Therapeutics (United States) Revenue: by Geography 2020
  • Figure 47. Sun Pharma (India) Revenue, Net Income and Gross profit
  • Figure 48. Sun Pharma (India) Revenue: by Geography 2020
  • Figure 49. Global Codeine Drug: by Type USD Million (2021-2026)
  • Figure 50. Global Codeine Drug: by Sales Channels USD Million (2021-2026)
  • Figure 51. Global Codeine Drug: by End Users USD Million (2021-2026)
  • Figure 52. Global Codeine Drug: by Treatment USD Million (2021-2026)
  • Figure 53. Global Codeine Drug: by Form USD Million (2021-2026)
  • Figure 54. South America Codeine Drug Share (%), by Country
  • Figure 55. Asia Pacific Codeine Drug Share (%), by Country
  • Figure 56. Europe Codeine Drug Share (%), by Country
  • Figure 57. MEA Codeine Drug Share (%), by Country
  • Figure 58. North America Codeine Drug Share (%), by Country
  • Figure 59. Global Codeine Drug: by Type K Tons (2021-2026)
  • Figure 60. Global Codeine Drug: by Sales Channels K Tons (2021-2026)
  • Figure 61. Global Codeine Drug: by End Users K Tons (2021-2026)
  • Figure 62. Global Codeine Drug: by Treatment K Tons (2021-2026)
  • Figure 63. Global Codeine Drug: by Form K Tons (2021-2026)
  • Figure 64. South America Codeine Drug Share (%), by Country
  • Figure 65. Asia Pacific Codeine Drug Share (%), by Country
  • Figure 66. Europe Codeine Drug Share (%), by Country
  • Figure 67. MEA Codeine Drug Share (%), by Country
  • Figure 68. North America Codeine Drug Share (%), by Country
  • Figure 69. Global Codeine Drug: by Type USD/Units (2021-2026)
Some of the key companies/manufacturers profiled in the report
  • Pfizer (United States)
  • Abbott (United States)
  • Merck (United States)
  • Sanofi (France)
  • Johnson and Johnson (United States)
  • Janssen Pharmaceuticals (Belgium)
  • Mallinckrodt Pharmaceuticals (United Kingdom)
  • Endo Pharmaceuticals (Ireland)
  • Assertio Therapeutics (United States)
  • Sun Pharma (India)
Additional players considered in the study are as follows:
Cipla (India) , Purdue Pharma (United States) , Actavis Plc (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation